CAS 65429-42-7
:(6a,11b,16a,17a)-6,9-Difluor-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)androsta-1,4-dien-17-carbonsäure
- (6alpha,11beta,16alpha,17alpha)-6,9-Difluoro-11-hydroxy-16-methyl-3-oxo-17-(propionyloxy)androsta-1,4-diene-17-carboxylic acid
- Androsta-1,4-Diene-17-Carboxylic Acid, 6,9-Difluoro-11-Hydroxy-16-Methyl-3-Oxo-17-(1-Oxopropoxy)-, (6Alpha,11Beta,16Alpha,17Alpha)-
- (6Alpha,11Beta,16Alpha,17Alpha)-6,9-Difluoro-11-Hydroxy-16-Methyl-3-Oxo-17-(Propanoyloxy)Androsta-1,4-Diene-17-Carboxylic Acid
Fluticasone Propionate Acid ((6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(propionyloxy)-6,7,8,9,10,11,12,13,14,15, 16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylic acid)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFormel:C24H30F2O6Farbe und Form:White Off-White SolidMolekulargewicht:452.20105Fluticasone 17b-Carboxylic Acid Propionate
CAS:Formel:C24H30F2O6Reinheit:98%Farbe und Form:SolidMolekulargewicht:452.4882Fluticasone Propionate EP Impurity A
CAS:Formel:C24H30F2O6Farbe und Form:White To Off-White SolidMolekulargewicht:452.49Fluticasone 17β-Carboxylic Acid Propionate
CAS:Impurity Fluticasone Propionate EP Impurity A
Applications An impurity formed in the synthesis of Fluticasone propionate (F599500).
References Phillips, G., et al.: J. Med. Chem., 37, 3717 (1994),Formel:C24H30F2O6Farbe und Form:WhiteMolekulargewicht:452.49Fluticasone 17Beta-Carboxylic Acid Propionate-d3
CAS:Kontrolliertes ProduktApplications Labelled Fluticasone 17β-Carboxylic Acid Propionate (F599495). An impurity formed in the synthesis of Fluticasone propionate (F599500).
References Phillips, G., et al.: J. Med. Chem., 37, 3717 (1994),Formel:C24H27D3F2O6Farbe und Form:WhiteMolekulargewicht:455.51Fluticasone 17b-carboxylic acid propionate
CAS:Kontrolliertes ProduktFluticasone propionate is a synthetic corticosteroid that is used in the treatment of asthma. It is an esterified prodrug which requires hydrolysis by esterases in order to become active. Fluticasone propionate has shown clinical efficacy with oral administration and can be administered by inhalation or through the skin. This drug is available as a deuterated form for use in nuclear magnetic resonance spectroscopy and reaction monitoring. It also has a linear range of 10-1000 ng/mL and a quadrupole mass spectrometer detection limit of 0.1 pmol, which allows it to be used for plasma samples and reconstituted drugs.
Formel:C24H30F2O6Reinheit:(¹H-Nmr) Min. 95 Area-%Farbe und Form:White Off-White PowderMolekulargewicht:452.49 g/mol







